6 completed, 1 terminated, 1 unknown. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Kaletra: new trials by email Literature Review of Kaletra trials Research Report on Kaletra
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab - COVID-19, Hospitalized COVID-19 Patients | Phase 1 | Unknown | Lebanese University | 1000 | 2020-03-28 | 2024-02-06 |
| GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir Darunavir, Etravirine, Ritonavir - Healthy Volunteer | Phase 1 | Completed | ViiV Healthcare | 17 | 2009-04-01 | 2012-02-22 |
| Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF) Lopinavir/ritonavir - HIV Infections | Phase 1 | Completed | Radboud University Medical Center | 12 | 2008-09-01 | 2020-11-12 |
| A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects lopinavir/ritonavir, rifabutin - HIV, Tuberculosis | Phase 1 | Terminated | Abbott | 15 | 2008-08-01 | 2010-11-02 |
| The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet Kaletra - Pregnancy, HIV | Phase 1 | Completed | University of North Carolina, Chapel Hill | 12 | 2007-01-01 | 2011-05-13 |
| Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations lopinavir/ritonavir, efavirenz, artemether/lumefantrine - HIV Infections, Malaria | Phase 1 | Completed | Fran Aweeka | 38 | 2005-07-01 | 2013-06-06 |
| Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV Nevirapine, Efavirenz, Indinavir/ritonavir - HIV Infections | Phase 1 | Completed | Germans Trias i Pujol Hospital | 675 | 2005-01-01 | 2019-12-04 |
| ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects Lopinavir/Ritonavir, Lamivudine, Stavudine - HIV Infections | Phase 1 / Phase 2 | Completed | Abbott | 100 | 1997-11-01 | 2008-04-03 |
HIV Infections (4) · Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Disease Progression (1) · Inflammation (1) · Malaria (1) · Tuberculosis (1)
Abbott (2) · Fran Aweeka (1) · Germans Trias i Pujol Hospital (1) · Lebanese University (1) · Radboud University Medical Center (1) · University of North Carolina, Chapel Hill (1) · ViiV Healthcare (1)
United States (5) · Lebanon (1) · Netherlands (1) · Spain (1)
Angela DM Kashuba, PharmD (1) · Angela Nilius, MD (1) · Bonaventura Clotet, MD, PhD (1) · David M Burger (1) · Francesca T Aweeka, PharmD (1) · George Hanna, MD (1) · Kristine B Patterson, MD (1) · Nehman Makdissy, Professor (1)
2004 (1)